WO2015001286A1 - Biocapteur - Google Patents

Biocapteur Download PDF

Info

Publication number
WO2015001286A1
WO2015001286A1 PCT/GB2014/000260 GB2014000260W WO2015001286A1 WO 2015001286 A1 WO2015001286 A1 WO 2015001286A1 GB 2014000260 W GB2014000260 W GB 2014000260W WO 2015001286 A1 WO2015001286 A1 WO 2015001286A1
Authority
WO
WIPO (PCT)
Prior art keywords
sensor according
sensor
flow path
graphene
molecule
Prior art date
Application number
PCT/GB2014/000260
Other languages
English (en)
Inventor
Owen GUY
Original Assignee
Swansea University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Swansea University filed Critical Swansea University
Priority to GB1601669.3A priority Critical patent/GB2530700A/en
Publication of WO2015001286A1 publication Critical patent/WO2015001286A1/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/403—Cells and electrode assemblies
    • G01N27/414—Ion-sensitive or chemical field-effect transistors, i.e. ISFETS or CHEMFETS
    • G01N27/4145—Ion-sensitive or chemical field-effect transistors, i.e. ISFETS or CHEMFETS specially adapted for biomolecules, e.g. gate electrode with immobilised receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/403—Cells and electrode assemblies
    • G01N27/414—Ion-sensitive or chemical field-effect transistors, i.e. ISFETS or CHEMFETS
    • G01N27/4146—Ion-sensitive or chemical field-effect transistors, i.e. ISFETS or CHEMFETS involving nanosized elements, e.g. nanotubes, nanowires
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G01N33/5438—Electrodes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors

Definitions

  • the present disclosure relates to a biosensor which is functionalised and in particular but not exclusively the biosensor is used to monitor hormones, and in particular those related to stress.
  • biosensors Sensors for detecting biological molecules, termed biosensors, are widely used.
  • a large variety of biosensors have been developed for sensing or detecting biological molecules (organic molecules produced by or occurring in organisms) with increasing resolution and specificity.
  • biological molecules includes, but is not limited to polymeric molecules occurring in nature and their analogues, such as proteins, polysaccharides, and nucleic acids as well as small molecules such as primary metabolites, secondary metabolites, and natural products.
  • biosensors rely on the general principle of generating an electrical signal if the presence or absence of a biological molecule is detected.
  • Structured semiconductor materials are in some cases used to form channels or other structures at the micrometer scale (micro-scale) or nanometer scale (nano-scale).
  • Graphene is a planar sheet of carbon atoms forming a honey-comb shaped crystal lattice and has gained increasing interests for its electronic properties.
  • graphene is generally not the preferred choice of material for biological applications because of its low affinity for biological monitoring.
  • Structures that are similar to graphene have also been used, such as carbon nanotubes, graphite and fullerenes but again there are biocompatibility issues which are based on the physical properties including the shape or length of structures such as nanotubes.
  • Cortisol levels in saliva are normally between 3 nM and 27 nM, and can be significantly higher in stress suffers. However, what is an elevated level for one individual may be quite normal and not potentially detrimental to health for another individual. Stress costs the UK economy £26bn and affects many people's quality of life.
  • sensors have involved taking a sample in a hospital or medical practitioner environment and then having the sample analysed either as an individual test or by sending off the sample to be analysed in a laboratory. The taking of the sample can lead to increased stress and also if the sample is not analysed immediately the levels of markers in the sample, can decay, leading to a false indication of the true levels of indicators for the individual from whom the sample is taken.
  • test results should be available immediately after taking a stress test to get a meaningful picture of the condition of an individual at a point in time. Also, currently there is no means for analysing stress levels for an individual and determining whether this is a normal level for that individual or whether it is an aberration from what is normal and so potential detrimental to health. In particular there are no means of monitoring stress in real time over a particular time period so that trends in stress levels can be evaluated.
  • the present invention seeks to overcome the problems of the prior art by providing a very sensitive biosensor that can operate if required in real time to give a selective measurement of the amount or concentration of biological molecules in the body.
  • the invention provides a way of determining anomalies in the levels of chemicals in the body and so gives an early indication of potential health risks.
  • a sensor for detecting the presence of at least one biological molecule comprising: - a flow path
  • At least one linker attached to at least a portion of the flow path, wherein the at least one linker has a binding affinity for the at least one biological molecule, said biological molecule being associated with stress in the body.
  • the flow path is provided by a graphene body having a surface with a channel etched in said surface to form the flow path.
  • the flow path is a silicon nanowire that is used as the conductive sensor channel for the substrate material.
  • the silicon nanowire can carry a current that is use to detect the sample material in the flow path.
  • the graphene body is arranged on a non conductive surface.
  • non conductive substrates include materials based on silicon such as silicon dioxide, silicon nitride, silicon carbide or polymers such as Polydimethylsiloxane (PDMS).
  • the at least two electrical contacts are arranged at opposite ends of the flow path.
  • the senor has at least three electrical contacts.
  • two contacts are arranged at opposite ends of the flow path, and a third contact is arranged either in a lateral position relative to the flow path forming a lateral transistor structure or the third contact is on the back of the substrate so providing a field path or back-gate transistor structure.
  • a further electrical contact which acts as a reference electrode, counter or auxiliary electrode.
  • the further contact is incorporated onto the same wafer as the sensor device or is fabricated on a separate substrate.
  • the contacts are produced on the substrate by lithographically or by printing, e.g. 3D printing.
  • the at least one linker includes an amine group or a carboxy group.
  • the at least one linker may be a linker molecule or a group of molecules.
  • the at least one linker may comprise at least one of an aniline, a diazonium ion or diazonium salt, APTES (3-Aminopropyl)triethoxysilane (APTES), or other amine or carboxy terminated moiety compounds and a sensing molecule.
  • APTES 3-Aminopropyl)triethoxysilane
  • the at least one linker is selected from one or more of a receptor molecule, an amino acid, an enzyme, an antibody for the at least one biological molecule.
  • the sensing molecule may be at least one of a biomarker, a receptor, an amino acid, an enzyme, or an antibody for the at least one biological molecule
  • the at least on linker is a receptor for a biological molecule associated with stress in the body.
  • the receptor is an antibody bioreceptor for Cortisol. Binding of Cortisol to its complementary antibody, produces a detectable electrical change in the flow channel formed of nano wires or nanochannels.
  • the stress associated biological molecule is one or more of Cortisol, Serotonin, Adrenaline, Nor-adrenaline, Dopamine, Human Growth Hormone (HgH), Oxytocin, Melatonin or, Dehydroepiandrosterone (DHEA).
  • the sensor may be a multichannel sensor having one or more flow paths, each being able to carry a separate sample material and each having a linker for a specified biological molecule.
  • the flow paths are arranged in pairs, with one of the pair of flow paths providing a control and the other flow path of the pair being arranged to monitor a sample material from an individual.
  • the control measurement allows for the delineation between responses of a device to non specific interactions compared with the response of the device to a specific chemical in a biological fluid, for example a target biomolecule such as Cortisol.
  • the senor is in communication with a data recorder that can analyse the relative levels of the biological molecules for the individual.
  • the senor is combined with microfluidics that can receive a flow of saliva from the individual for detection and analysis of the biological molecule.
  • the senor is provided as a patch that can be releasably secured to the body and which can receive a flow through of blood from the individual and which can analyse several biological molecules at the same time.
  • Patch type sensors are particularly suited to blood monitoring devices.
  • the senor is provided as an implant which can receive a flow through of blood from the individual and which can analyse several biological molecules on the one sensor.
  • the analysis can be carried out for a number of biological molecules on the one sensor at the same time.
  • By analysing several materials at a single period in time then it is possible to gain an overall picture of the chemical/biological profile of an individual at a set period in time.
  • the profile can give an indication of the different enzymes/hormones steroids that are associated with a particular aspect of that individual and their relative levels in the body for that individual.
  • the measurement may be in real time. If measurements are carried out in real time then a profile of the hormonal/enzymatic characteristics of that individual may be monitored over time.
  • Figure 1 shows: a perspective view of a multichannel graphene or silicon nanowire sensor according to an embodiment of the invention
  • Figure 2 shows: an individual nanowire device
  • Figure 3a shows: a schematic of a process for the functionalization of graphene or silicon nanowire according to an embodiment of the invention
  • Figure 3b shows: a schematic process for the functionalization of graphene or silicon using APTES solution
  • Figure 4 shows: a top view of a microfluidic sensor package
  • Figure 5 shows: a perspective view of a sensor and multichannel graphene or silicon nanowire layer
  • Figure 6 shows: a cross section of a nanostructure incorporated in a sensor
  • Figure 7 shows: a sensor implemented as a nano- transmitter.
  • the microchannel part of a sensor is illustrated in Figure 1, and this structure is generally shown as 1 in the figure.
  • the structure consists of a substrate 10 and there is a plurality of nanostructures 20 on the substrate.
  • the nanostructures are generally in alignment forming blocks 11, 12 of nanostructures with insulators between them.
  • Each nanostructure is formed of a nano-channel 21 between two metal contacts 22.
  • Figure 2 shows an individual nanostructure with a representation of the microchannel being functionalised with a functionalised surface 23. Current is passed between the two metal contacts, through the nanochannel.
  • the nano-channel is typically made from graphene (on a silicon carbide substrate).
  • the sensor can be graphene or a silicon nanowire (SiNW) with the channel being functionalised (represented by 23) with a bioreceptor such as an antibody.
  • the bioreceptor may be an antibody, enzyme or other protein or nucleic acid. This antibody specifically and selectively detects the disease biomarker (D).
  • a sensor usually comprises one channel and two or more metal contacts or electrodes 22.
  • the graphene channels and thus the individual sensors are separated by a silicon dioxide (Si0 2 ) layer providing electric insulation 15 between the metal contacts and the graphene channels.
  • the metal contacts or metal electrodes may be silver probes or may be made from other metals such as, for example, titanium, nickel, copper, gold or aluminium.
  • the metal contacts may or may not be in contact with the graphene channel.
  • the electrodes may have different shapes such as triangles or squares.
  • the shape of the metal contacts or electrodes may be adapted to the specific needs of a specific biosensor.
  • a measurement channel made from graphene is formed between two of the electrodes. The two electrodes are arranged at opposite ends of the channel. As an example, some of the channels may comprise a third electrode arranged at one side of the channel for operating these sensors as a lateral transistor.
  • a SiC substrate it can be semiconducting or semi-insulating, or a combination of semiconducting or semi-insulating depending on the conductivity.
  • the difference in conductivity arises from doping of the SiC as known in the art. If there are an excess of one type of impurity or dopant atom in the SiC, the SiC the conductivity will be increased and the SiC substrate becomes semi-conducting. If there is little or no excess, the SiC will be virtually insulating or semi-insulating.
  • the graphene layer is grown, for example by epitaxial growth or sublimation growth, on the SiC substrate.
  • the graphene layer may, for example have the shape of a graphene channel.
  • the two metal contacts 22 are arranged on top of the graphene layer and form end points of the graphene channel 21.
  • the metal contacts may be electrodes and can be made of silver material or any other material known in the art.
  • a metallic back electrode can be provided on the back surface of the SiC substrate and this may be of the same material as the metal contacts 22. However it could be the case that the electrode and contact are of different material.
  • the senor comprises a SiC substrate with a back side electrode and a semi-insulating SiC layer is arranged on the silicon carbide substrate and a graphene layer is arranged (i. e. grown) on top of the semi-insulating SiC layer.
  • the semi-insulating layer electrically isolates the highly conductive graphene layer from the SiC substrate. If the SiC substrate is conductive, some of the current in any graphene device could potentially travel through the SiC substrate.
  • Semi-insulating SiC can also be used as the SiC substrate and metal contacts and are arranged on top of the graphene layer.
  • the graphene channel 21 may have a thickness or channel width about 20 nm to about 200 nm, although thicker channels may be used, i.e. up to 400nm.
  • the length of the channel may vary from about 200 nm to 10 ⁇ .
  • the structured graphene channel may therefore be termed a "nano-channel".
  • the graphene channel may be made larger and thus be at the micrometer scale or sub- millimetre scale.
  • the graphene channel may be open at the topside to allow access of biological molecules to the graphene channel. It may also be that fluid is allowed to access the graphene channel via sealed microfluidic channels.
  • the two metal contacts or metal electrodes 22 may be much larger in size compared to the width of the graphene channel.
  • the dimension of the metal contacts or metal electrodes may have a surface area of, for example, about 20 to 50 ⁇ 2 . However, different electrode sizes can be used.
  • Using a back electrode allows the operation of the graphene channel as a field effect transistor.
  • the electric properties of the graphene channel may also be determined by measuring the electrical resistance of, a current passing through, the impedance of other parameters of the graphene channel. The measurement of the electrical property can rely on the principle that the electrical property changes if a biological molecule or a plurality of biological molecules binds to the graphene channel.
  • This change in the electrical property may be detected as an electrical signal which can be further amplified.
  • a back electrode may be omitted depending on the electrical property to be detected and the type of sensor that is to be used.
  • the graphene channel is functionalized to enable the binding or attachment of specific biological molecules.
  • the channel structures shown as examples in Figure 1 may be formed as graphene layer or multi-layer epitaxial graphene grown using epitaxial growth.
  • the layer thickness may be between one and about 10 atomic layers or more.
  • the graphene layer may be grown on a substrate using CVD and used on the substrate or transferred onto another substrate for use.
  • the SiC substrate may be a commercially available SiC wafer.
  • the growth process comprises sublimation of silicon from the first few surface layers of the SiC substrate. Carbon atoms left behind after silicon sublimation, reconstruct themselves into a hexagonal graphene structure.
  • the growth process involves heating the SiC substrate at between about 1000 and 1800°C . under vacuum conditions, for example ultra high vacuum conditions with pressures lower than 10 "9 mbar.
  • An alternative growth process involves higher temperatures (for example up to about 1500 to 1700°C or more) and higher pressures.
  • an epitaxial graphene layer is grown on the SiC substrate by annealing SiC under ultra high vacuum (UHV) conditions, for example for about 10 minutes at about 1250°C.
  • UHV ultra high vacuum
  • the temperature and time duration may be varied to control the thickness of the graphene layer.
  • the grapheme layer may also be grown using an atmosphere such as Argon.
  • the graphene layer is then patterned by depositing a layer of electron beam resist and subsequently patterning using electron beam lithography.
  • the resist is developed and the exposed graphene is then etched away using an oxygen plasma etch. After striping the remaining resist, graphene channels remain on the SiC substrate.
  • the metal electrodes can then be fabricated by depositing a thin film of metal from 100 nm to 1 um in thickness.
  • a Photoresist is then deposited on top of the metal layer and patterned using a standard photolithography process. Finally the thin film of metal is etched, leaving behind the final device structures.
  • the alternative sensor, fabricated using a SiNW may be fabricated using asilicon on insulator wafer and etching a silicon nanowire structure from the silicon layer - leaving a Silicon nanowire on an insulating silicon dioxide layer.
  • the silicon nanowire can be patterened using electron beam lithography or photolithography followed by silicon etching using dry plasma etching or wet chemical etching. Following this process metal contacts are deposited and contacted to the silicon nanowires.
  • the attachment of the bioreceptor onto the graphene (or SiNW) surface requires two parallel processes: (i) the surface modification and (ii) the subsequent antibody attachment.
  • the antibody may be attached using the diazonium chemistry as shown in Figure 3a or using (3-Aminopropyl)triethoxysilane)APTES attachment chemistry Figure 3b.
  • the graphene channels may be chemically functionalized to have a binding affinity for the biological molecule.
  • the binding affinity may be specific for the biological molecule to be detected with the sensor.
  • the biological molecule to be detected is also termed target molecule and for stress analysis the molecule is typically a steroid, for example Cortisol.
  • a possible mechanism for nitrobenzene attachment to graphene and subsequent electrochemical reduction to aniline is the attachment of a diazonium salt.
  • the diazonium salt is attached to the graphene surface in order to attach a nitrobenzene or a nitrobenzene derivate to the graphene surface.
  • the nitro group of the nitrobenzene may than be reduced to an amine, such as phenyl amine (IV).
  • the resulting nitrophenyl amine has an amine group that can be used as such as a linker.
  • a sensing molecule can be attached to the amine group of the aniline or to the carboxyl group of the benzoic acid.
  • the sensing molecules may comprise a biomarker, a receptor, an antibody, an amino acid, an enzyme or any other biological molecule appropriate for specifically binding a target molecule, for example a molecule associated with stress such as a corticosteroid.
  • a target molecule for example a molecule associated with stress such as a corticosteroid.
  • the receptor molecule is highly specific to the target molecule, only these target molecules will bind to the sensing molecule and thus to the graphene surface, thereby changing the electrical properties of the graphene surface.
  • Other biological molecules or any other molecule coming into contact with the graphene surface or the receptor molecule will not bind specifically or covalently to the graphene surface or the sensing molecule and have little effect or no effect on the electrical properties of the graphene surface.
  • the graphene may also be functionalized using ethandiamine for the linker and the ethandiamine may be attached to carboxylated graphene or graphene oxide to give amine functionalised graphene to which a sensing molecule can be bound.
  • the graphene may also be functionalized by a NH 3 plasma treatment of the graphene surface.
  • An alternative functionalization process is performed by firstly terminating the silicon or graphene with -OH groups, for example, using the Fenton reaction, then reacted with 3- Aminopropyl-triethoxysilane (APTES) in order to obtain an amine-terminated surface.
  • APTES 3- Aminopropyl-triethoxysilane
  • the carboxylic acids on the antibody are activated.
  • the majority of amine groups on the antibody are blocked using Di-tert-butyl dicarbonate.
  • the antibody can now be reacted with the amine on the surface.
  • the groups blocking the amines on the antibody are subsequently removed by mild acidic treatment.
  • the functionalisation reaction may be carried out in situ i.e. in the microfluidic channel. To do this requires a three electrode device and this avoids using additional and external Ag/AgCl and Platinum wire electrodes because the 3 electrodes are thus integrated into one unit.
  • the nanostructures 10 may be placed in a housing 30 formed of a surround 32 which formed a border around the nanostructures.
  • a dividing surface 35 can form a border between separate micro channels 21.
  • the dividers provide an opening to each separated micro channel and so a sample can be placed on each separate micro channel.
  • Each micro channel may be functionalised with different bioreceptors or it could be that different levels of the same bioreceptor are used for each channel so a comparative or qualitative study of samples can be made.
  • a control could be provided in one channel to show levels that are considered to be in a normal range so an indication can be given if the levels measured are outside those that would be considered normal, either for the population as a whole or based on previous readings for that individual.
  • FIG 5 shows a complete sensor having a lid 31 which is formed of the surround 32 and dividers 35 as shown in Figure 4.
  • the lid 31 may be secured to a base 36.
  • a nanostructure 10 may be placed between the lid 31 and base 36.
  • a window 34 in the lid provides access to the nanostructure 10 having micro channels 2 land contacts 22.
  • Figure 6 we a cross section through a sensor where there is a silicon carbide substrate 310 and a graphene layer 320 which is grown on top of the semi-insulating layer 360.
  • Metal contacts 331 and 332 are on top of the graphene layer 320 and back side electrode 340 forms a thirds contact.
  • Figure 7 shows a substrate 550 with a graphene channel 520 between metal contacts of electrodes 531 and 532.
  • the third contact is a gate contact 535 which means that the sensor may be operated as a lateral field transistor which changes its electrical properties when one or more biological molecules are attached to the graphene channel 510.
  • a back electrode as shown in Figure 6, may or may not be present.
  • the lid may have an electrode incorporated into it that can be used either during the functionalization process or during the sample measurement process.
  • This electrode may be produced lithographically or printed and may be comprised of a metal such as Al, Au, Pt, Ni, Ti, Cu, Ag or a conductive material such as graphite, graphene, carbon nanotubes (CNTs) or conductive polymers.
  • the sensor may also have a power supply such as a battery and may also include a transmitter 37 that can send data information to a receiver.
  • a power supply such as a battery
  • the window 24 can include a needle or array of micro needles (not shown) that are in contact with the interstitial fluid in the skin of an individual.
  • the sensor may include an alternative microfluidic system which can deliver fluids such as saliva, blood, urine, interstitial fluid or other bodily fluids onto the sensor. The sensor can then take measurements of particular components in the body over a period of time to provide a measurement of levels of molecules over a period of time.
  • the sensors can be used to evaluate corticosteroid hormones such as Cortisol and
  • Serotonin and also in addition other stress hormone markers including Adrenaline, Nor adrenaline, Dopamine, and Human Growth Hormone (HgH), Oxytocin, Melatonin, Dehydroepiandrosterone (DHEA).
  • HgH Human Growth Hormone
  • Oxytocin Oxytocin
  • Melatonin Melatonin
  • DHEA Dehydroepiandrosterone
  • the senor can be incorporated in a hand held device that medical practitioners can use or it can be included in an implant for continual monitoring of the body.
  • the device allows for the detection of sub nano Molar concentrations of Cortisol and the sensor can be calibrated for clinically relevant concentration ranges.
  • the senor can be integrated with a microfluidic device with the sensor being part of a disposable sensor package, where the part of the sensor coming into contact with body fluids can be removed once used and disposed of.
  • the sensor can be integrated with hand held electronics where the sensor can be inserted in a reader, much like a "biochip credit card” using hand-held “card reader” so that results of the sampling can be read and if necessary analyzed.
  • the sensor can be used for the testing of saliva, urine, and interstitial fluid samples as well as analysis of blood samples.
  • nano-biosensor is particularly useful for the rapid detection of stress hormones that can be at very low levels in the body.
  • nanowires and/or nano-channels have extremely high surface to volume ratios, making them extremely sensitive to interactions with their surfaces. In combination with excellent electronic conduction properties, this makes nano-channel sensors ideal for the detection of biomarkers at very low concentrations.
  • nano-channel electrochemical sensors are being used, a number of current-voltage measurements over a defined time period can be taken to observe trends in levels of compounds in the body. This yields information on the change of resistance over time so providing information on diffusion controlled reactions which means that quantitative information and not just qualitative can be obtained.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microelectronics & Electronic Packaging (AREA)
  • Electrochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Nanotechnology (AREA)
  • Endocrinology (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)

Abstract

L'invention concerne un capteur (1) qui est formé d'une nanostructure à base de graphène ou de silicium (10) ayant un trajet d'écoulement (21) qui peut être un canal ou un nanofil. Le trajet d'écoulement est fonctionnalisé pour attirer certaines molécules. Le trajet d'écoulement présente des contacts (22) aux deux extrémités et le chargement du trajet d'écoulement fonctionnalisé modifie la charge sur ce trajet et donne une mesure des molécules. Le capteur permet d'obtenir un dispositif particulièrement sensible qui peut surveiller un certain nombre de biomolécules en temps réel et, en particulier, des molécules associées au stress.
PCT/GB2014/000260 2013-07-01 2014-06-27 Biocapteur WO2015001286A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1601669.3A GB2530700A (en) 2013-07-01 2014-06-27 Biosensor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1311760.1 2013-07-01
GBGB1311760.1A GB201311760D0 (en) 2013-07-01 2013-07-01 Biosensor

Publications (1)

Publication Number Publication Date
WO2015001286A1 true WO2015001286A1 (fr) 2015-01-08

Family

ID=48999319

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2014/000260 WO2015001286A1 (fr) 2013-07-01 2014-06-27 Biocapteur

Country Status (2)

Country Link
GB (2) GB201311760D0 (fr)
WO (1) WO2015001286A1 (fr)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3131121A1 (fr) * 2015-08-12 2017-02-15 Nokia Technologies Oy Appareil à effet de champ à base de graphène et procédés associés
CN107177584A (zh) * 2017-06-18 2017-09-19 天津大学 用于青霉素合成的整体型固定化酶的制备方法
EP3214435A4 (fr) * 2015-12-30 2018-07-04 Ndd, Inc. Dispositif de biodétection
CN108828032A (zh) * 2018-09-18 2018-11-16 天津博硕科技有限公司 一种在线电化学检测装置、方法及电化学免疫分析仪
RU2697701C1 (ru) * 2018-12-28 2019-08-19 федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный технический университет имени Н.Э. Баумана (национальный исследовательский университет)" (МГТУ им. Н.Э. Баумана) Способ изготовления биологического сенсора на основе оксида графена и биологический сенсор на гибкой подложке
CN113413933A (zh) * 2021-07-02 2021-09-21 山东大学第二医院 一种基于玻璃微球的微流控芯片及其应用
CN115501007A (zh) * 2022-11-04 2022-12-23 清华大学 高分子骨植入物多通道传感器的设计及加工方法
CN115561295A (zh) * 2022-12-06 2023-01-03 有研(广东)新材料技术研究院 一种硅纳米线场效应葡萄糖传感器及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010059687A2 (fr) * 2008-11-18 2010-05-27 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Semi-conducteur pour mesurer des interactions biologiques
WO2011004136A1 (fr) * 2009-07-07 2011-01-13 Uws Ventures Limited Biodétecteur à base de graphène

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010059687A2 (fr) * 2008-11-18 2010-05-27 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Semi-conducteur pour mesurer des interactions biologiques
WO2011004136A1 (fr) * 2009-07-07 2011-01-13 Uws Ventures Limited Biodétecteur à base de graphène

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
JIAO LUYANG ET AL: "Aptamer and graphene-based electrochemical biosensor for dopamine determination with high sensitivity and selectivity", MICRO & NANO LETTERS, THE INSTITUTION OF ENGINEERING AND TECHNOLOGY, MICHAEL FARADAY HOUSE, SIX HILLS WAY, STEVENAGE, HERTS. SG1 2AY, UK, vol. 8, no. 12, 1 December 2013 (2013-12-01), pages 903 - 905, XP006047957, DOI: 10.1049/MNL.2013.0626 *
OWEN J GUY ET AL: "Fabrication of ultrasensitive graphene nanobiosensors", SENSORS, 2010 IEEE, IEEE, PISCATAWAY, NJ, USA, 1 November 2010 (2010-11-01), pages 907 - 912, XP031978236, ISBN: 978-1-4244-8170-5, DOI: 10.1109/ICSENS.2010.5690883 *
OWEN J. GUY ET AL: "Graphene Nano-Biosensors for Detection of Cancer Risk", MATERIALS SCIENCE FORUM, vol. 711, 1 January 2012 (2012-01-01), pages 246 - 252, XP055151660, DOI: 10.4028/www.scientific.net/MSF.711.246 *
TEIXEIRA SOFIA ET AL: "Epitaxial graphene immunosensor for human chorionic gonadotropin", SENSORS AND ACTUATORS B: CHEMICAL: INTERNATIONAL JOURNAL DEVOTED TO RESEARCH AND DEVELOPMENT OF PHYSICAL AND CHEMICAL TRANSDUCERS, vol. 190, 23 September 2013 (2013-09-23), pages 723 - 729, XP028764442, ISSN: 0925-4005, DOI: 10.1016/J.SNB.2013.09.019 *
YAN MAO ET AL: "Electrochemical sensor for dopamine based on a novel graphene-molecular imprinted polymers composite recognition element", BIOSENSORS AND BIOELECTRONICS, ELSEVIER BV, NL, vol. 28, no. 1, 14 July 2011 (2011-07-14), pages 291 - 297, XP028276205, ISSN: 0956-5663, [retrieved on 20110723], DOI: 10.1016/J.BIOS.2011.07.034 *

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3131121A1 (fr) * 2015-08-12 2017-02-15 Nokia Technologies Oy Appareil à effet de champ à base de graphène et procédés associés
WO2017025661A1 (fr) * 2015-08-12 2017-02-16 Nokia Technologies Oy Appareil à effet de champ et procédés associés
EP3214435A4 (fr) * 2015-12-30 2018-07-04 Ndd, Inc. Dispositif de biodétection
US10585093B2 (en) 2015-12-30 2020-03-10 Ndd, Inc. Bio-sensing device
CN107177584A (zh) * 2017-06-18 2017-09-19 天津大学 用于青霉素合成的整体型固定化酶的制备方法
CN108828032A (zh) * 2018-09-18 2018-11-16 天津博硕科技有限公司 一种在线电化学检测装置、方法及电化学免疫分析仪
CN108828032B (zh) * 2018-09-18 2024-04-19 天津博硕科技有限公司 一种在线电化学检测装置、方法及电化学免疫分析仪
RU2697701C1 (ru) * 2018-12-28 2019-08-19 федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный технический университет имени Н.Э. Баумана (национальный исследовательский университет)" (МГТУ им. Н.Э. Баумана) Способ изготовления биологического сенсора на основе оксида графена и биологический сенсор на гибкой подложке
CN113413933A (zh) * 2021-07-02 2021-09-21 山东大学第二医院 一种基于玻璃微球的微流控芯片及其应用
CN115501007A (zh) * 2022-11-04 2022-12-23 清华大学 高分子骨植入物多通道传感器的设计及加工方法
CN115501007B (zh) * 2022-11-04 2023-03-17 清华大学 高分子骨植入物多通道传感器的设计及加工方法
CN115561295A (zh) * 2022-12-06 2023-01-03 有研(广东)新材料技术研究院 一种硅纳米线场效应葡萄糖传感器及其制备方法

Also Published As

Publication number Publication date
GB201601669D0 (en) 2016-03-16
GB201311760D0 (en) 2013-08-14
GB2530700A (en) 2016-03-30

Similar Documents

Publication Publication Date Title
WO2015001286A1 (fr) Biocapteur
Sheibani et al. Extended gate field-effect-transistor for sensing cortisol stress hormone
Yan et al. Solution‐gated graphene transistors for chemical and biological sensors
US9506892B2 (en) Field-effect transistor, single-electron transistor and sensor using the same
Yu et al. Quantitative real-time detection of carcinoembryonic antigen (CEA) from pancreatic cyst fluid using 3-D surface molecular imprinting
Balakrishnan et al. Development of highly sensitive polysilicon nanogap with APTES/GOx based lab-on-chip biosensor to determine low levels of salivary glucose
Park et al. Applications of field-effect transistor (FET)-type biosensors
Hao et al. Modulating the linker immobilization density on aptameric graphene field effect transistors using an electric field
US20150038378A1 (en) Biocompatible graphene sensor
CN110337586A (zh) 用于检测至少一种流体样品中的至少一种分析物的分析物检测器
GB2489504A (en) A device for identifying the presence of a specific target molecule or biomarker by sensing an electrical property
Jung et al. Super-Nernstian pH sensor based on anomalous charge transfer doping of defect-engineered graphene
Wang et al. High-stability pH sensing with a few-layer MoS2 field-effect transistor
US20210382045A1 (en) Dynamic excitation and measurement of biochemical interactions
KR100999451B1 (ko) 전기분해 및 팔라듐의 수소 흡착을 이용한 피에이치 센서및 그 제조 방법
De et al. Integrated label-free silicon nanowire sensor arrays for (bio) chemical analysis
US11536721B2 (en) Electrochemical immunosensors
US20220091066A1 (en) Biofunctionalized three-dimensional (3d) graphene-based field-effect transistor (fet) sensor
WO2021210027A1 (fr) Dispositif de détection et de pronostic d'une maladie chronique et son procédé de détection
Varghese et al. Fabrication and modeling-based performance analysis of circular GaN MOSHEMT-based electrochemical sensors
US11988629B2 (en) Method of manufacturing a graphene-based biological field-effect transistor
EP4009045A1 (fr) Transistor à effet de champ à grille élargie avec couche de fonctionnalisation aptamère pour la mesure de la concentration d'hormones dans les biofluides et procédé de fabrication correspondant
Stern Label-free sensing with semiconducting nanowires
Fuhr et al. Tuning the pH Response of Monolayer Hexagonal Boron Nitride/Graphene Field-Effect Transistors
Majd et al. Microfluidic electrolyte-gated TiS3 nanoribbons-based field-effect transistor as ultrasensitive label-free immunosensor for prostate cancer marker analysis

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14755888

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 1601669

Country of ref document: GB

Kind code of ref document: A

Free format text: PCT FILING DATE = 20140627

122 Ep: pct application non-entry in european phase

Ref document number: 14755888

Country of ref document: EP

Kind code of ref document: A1